WilsonRMcKillopJHPearsonDWMCuthbertGFThomsonJA. Relapse of Graves' disease after medical therapy: Predictive values of thyroidal technetium-99 m uptake and serum thyroid stimulating hormone receptor antibody levels. J Nucl Med1986; 26: 1024–8.
2.
McGregorAMSmithBRHallRPetersenMMMillerMDewarPJ. Prediction of relapse in hyperthyroid Graves' disease. Lancet1980; i: 1101–3.
3.
SchleusenerHSchwanderJFischerCProspective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol1989; 120: 689–701.
4.
ShewringGSmithBR. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol1982; 17: 409–17.
5.
WilsonRFraserWDMcKillopJHThomsonJA. The prognostic values of TSH receptor binding and thyroid stimulating antibodies following antithyroid drug treatment for Graves' disease. Acta Endocrinol1989; 121: 666–70.
